Abstract Engineering the heterologous expression of polyketide synthases (PKSs) in Escherichia coli has led to the production of various valuable natural and unnatural products. However, the limited availability of malonyl-CoA (M-CoA) in E. coli remains a significant impediment to efficient polyketide overproduction. In this study, engineered E. coli strains were developed to augment M-CoA levels for enhanced polyketide production by introducing a malonate transport and CoA ligation pathway. Additionally, control over the M-CoA pool was achieved by disrupting the endogenous M-CoA pathway and reconstituting it through malonate supplementation. The engineered strains exhibited increased M-CoA, fatty acid and polyketide titers, improved substrate selectivity of PKSs, and successful production of > 99% uniformly labeled ¹³C polyketides. Adaptive laboratory evolution of these strains provided valuable insights into pathways governing the M-CoA pools and the accumulation of mutations that resulted in significantly increased M-CoA and polyketide levels. This approach not only enhances the utility of E. coli as a heterologous host for polyketides but also illuminates the intricate dynamics of M-CoA modulation in these systems.
No takes yet. Share an insight, caveat, or question.
Keasling et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: